Hartmut Warnken

Hartmut Warnken serves as the Chief Commercial Officer for VirtaMed since January 2025, following a notable tenure at Profound Medical Inc. from November 2015 to December 2024 where responsibilities included commercialization strategies across Europe, the Middle East, and Asia, achieving significant revenue growth and establishing key partnerships. Prior experience at IMRIS involved leading commercial operations across APAC and EMEA, driving substantial revenue increases and building strong KOL networks. Warnken's earlier roles at BrainLAB AG focused on intra-operative solutions, where Hartmut built global teams and executed major implementations in prestigious hospitals. Academic credentials include an MBA from ESCP Business School and engineering degrees from Technische Hochschule Augsburg and Hochschule für Technik und Wirtschaft Dresden, alongside military service in the German Navy.